Gastrointestinal Bleeding {#Sec1}
=========================

A.Classification Upper gastrointestinal (GI) bleeding is above the ligament of Treitz.Lower GI bleeding is below the ligament of Treitz.B.Etiology. The most common causes of acute GI bleeding requiring admission to the intensive care unit (ICU) are depicted in Table [6.1](#Tab6_1_69880_2_En){ref-type="table"}. The most common sources of GI bleeding in the ICU are gastroduodenal stress ulcerations.C.Diagnostic EvaluationHistoryAlthough the history and physical in a critically ill patient with acute GI bleeding may be limited by the patient's clinical condition, the following are points that need to be investigated:History of hematemesis or melenaTime of onsetAmount of bloodColor and characterDrug or alcohol use (i.e., nonsteroidal anti-inflammatory drug \[NSAID\], prednisone, warfarin)Past medical history (i.e., cirrhosis, peptic ulcer disease \[PUD\], inflammatory bowel disease \[IBD\], etc.)Physical ExaminationThe precise cause of acute GI bleeding is unlikely to be evident from physical examination alone (except in chronic liver disease, Osler-Rendu-Weber syndrome, or hemorrhoids).General Appearance: This may vary from the patient in no acute distress to the patient in hypovolemic shock.Vital Signs: Tachycardia, postural hypotension. An increase in heart rate of 10--20 beats per minute and drop in blood pressure of \>20 mmHg upon assumption of an upright position are generally indicative of significant, acute volume loss.Other Signs of Hypovolemia: Altered mental status, low urine output.Associated Findings: Petechiae, jaundice, hepatomegaly, and splenomegaly.Rectum: Look for hemorrhoids, fissures, etc. Examine stools for blood even if the patient has an upper GI source.A nasogastric (NG) tube should be placed in *all* patients with acute GI bleeding. The major advantages and disadvantages of NG tubes are shown in Table [6.2](#Tab6_2_69880_2_En){ref-type="table"}.Laboratory EvaluationAll patients admitted to the ICU with GI bleeding should undergo the laboratory tests depicted in Table [6.3](#Tab6_3_69880_2_En){ref-type="table"}.Radiologic EvaluationAll patients should undergo chest radiograph and abdominal x-rays. These may show evidence of perforation or obstruction and may indicate ischemic changes. Contrast studies have a low diagnostic yield and may be hazardous for the critically ill patient. They may also interfere with other diagnostic studies (i.e., endoscopy, angiography). Special tests may be required in the evaluation of acute GI bleeding. These includeSelective angiography may be used as a diagnostic as well as therapeutic tool (e.g., embolization). A bleeding rate at the time of the procedure ≥0.5 mL/min is needed for diagnosis.Radionuclide scans are sensitive in detecting lesions with lower bleeding rates.Endoscopy is indicated in the vast majority of patients requiring ICU admission for GI bleeding.Upper endoscopy is indicated when blood is obtained from the NG tube or when frank hematemesis is present.Flexible sigmoidoscopy should be performed initially if lower GI bleeding is suspected. If this is not diagnostic, colonoscopy should be considered.Special endoscopic procedures may be required (i.e., wireless video capsule endoscopy, push enteroscopy, double balloon enteroscopy)D.Initial ICU ManagementAs in any critically ill patient, the management of acute GI bleeding starts with assessment of the airway, breathing, and circulation (ABCs). A low threshold for endotracheal intubation is recommended in the event of clouding of consciousness or overt shock, to prevent aspiration.Insert at least two large-bore (16-gauge) IV catheters.Infuse blood, plasma expanders, and/or normal saline to maintain a mean arterial pressure ≥65 mmHg.Some authors still recommend NG placement in all patients with GI bleeding and lavage of the stomach until the return is clear. This practice is considered useful only in settings where emergency endoscopy is not available.Correction of preexisting coagulopathy (i.e., fresh frozen plasma \[FFP\], vitamin K, etc.).Proton-pump inhibitors and H~2~-receptor blockers to prevent further hemorrhage. Continuous infusions are preferred (i.e., pantoprazole \[Protonix\] 8 mg/h, ranitidine \[Zantac\] 150--300 mg/24 h IV infusion if the renal function is normal, or famotidine \[Pepcid\] 20 mg IV q12 h).Endoscopic and/or angiographic verification of the source of bleeding will allow more definitive therapy (i.e., thermal coagulation, injection therapy, fibrin sealant, endoclips, surgery).E.Specific Management of Selected ConditionsVariceal HemorrhageVasopressin Infusion: Start at 0.2--0.4 U/min (up to 1 U/min). Some of the major complications of vasopressin (i.e., myocardial ischemia) can be prevented by the co-administration of nitroglycerin.Alternatively, somatostatin-analogs can be utilized. Somatostatin inhibits the release of vasodilator hormones, such as glucagon, indirectly causing splanchnic vasoconstriction and decreased portal inflow:Octreotide is a long-acting analog of somatostatin.Dosing: 25--50 mcg I.V. bolus followed by continuous I.V. infusion of 25--50 mcg/hSclerotherapy: Indicated at the time of diagnostic endoscopy. Two or three treatments are usually done within a 10-day period.Balloon Tamponade: Temporizing measure only. It is usually reserved for hemorrhage that fails to stop after therapy with vasopressin and sclerotherapy. The routine use of Sengstaken--Blakemore or Minnesota tubes has almost disappeared with the advances in endoscopic therapy.Surgical Therapy: Every patient with a major esophageal bleed should receive surgical consultation in case an emergent intervention is needed. Indications for surgical therapy include the following: Child's class A or B patient in whom vital signs cannot be stabilized medically.Continuous bleeding for ≥48 h despite sclerotherapy and balloon tamponade.Third acute episode of esophageal bleeding in spite of previous sclerotherapy.Hemorrhage From Ulcers and Erosive LesionsEndoscopy therapy with sclerosing agents, or laser coagulation, or heater probe.Surgical intervention is indicated in cases ofVisible vascular pedicle on endoscopyTransfusion of 6 U blood in 24 hArterial spurtingActive Lower GI BleedingIf a lesion is reachable with sigmoidoscopy or colonoscopy, local therapy may be attempted (e.g., laser coagulation).Arterial embolization is indicated if the above fails.All patients with active lower GI bleeding should receive surgical consultation in case an emergent intervention is needed. Table 6.1.Etiologies of Acute GI BleedingUpperLowerEsophagusSmall intestineMucosal tearArteriovenous malformationsEsophageal ruptureInflammatory bowel disease ischemiaEsophagitisMeckel's diverticulumNeoplasmsNeoplasmsVaricesStomachLarge intestineArteriovenous malformationsDiverticulosisGastritis (any etiology)HemorrhoidsNeoplasmsInflammatory bowel disease infectionsPeptic ulcer diseaseIschemiaStress ulcersNeoplasmsDuodenumArteriovenous malformationsNeoplasms (*rare*)Peptic ulcer disease Table 6.2.Advantages and Disadvantages of NG Tubes in Acute GI BleedingAdvantagesDisadvantages1. Document the presence or absence of blood.1. Patient discomfort.2. Monitor rate of bleeding.2. Irritation of esophageal and/or gastric mucosa.3. To lavage and decompress the stomach.3. Increased incidence of sinusitis.4. Possible esophageal or gastric perforation. Table 6.3.Initial Laboratory Evaluation in GI BleedingComplete blood count (H/H should be repeated every 4 h until patient is stable or bleeding has been controlled)BUN, creatinine, and electrolytesPT, PTTType and cross-match for 2--8 U of PRBCs, FFPOther tests are ordered according to suspected or known underlying disease (i.e., LFTs, CK, etc.)*Abbreviations:* BUN, blood urea nitrogen; CK, creatine kinase; FFP, fresh-frozen plasma; H/H, hemoglobin/hematocrit; LFT, liver function tests; PRBCs, packed red blood cells; PT, prothrombin time; PTT, partial thromboplastin time.

Acute Mesenteric Ischemia {#Sec2}
=========================

A.Definition. Acute mesenteric ischemia (AMI) is an acute reduction in blood flow to the intestine leading to inadequate perfusion. AMI may be a reflection of generalized poor perfusion, or it may result from local pathology.B.Epidemiology. The incidence of AMI has increased over the past few decades. The rising incidence may be attributable to advances in medical technology and to new therapies extending the life of critically ill patients who are prone to develop AMI (e.g., elderly). The mortality in AMI is between 55 and 100%.C.EtiologyOcclusiveAtherosclerotic narrowing of the mesenteric bedSystemic emboli from any source (e.g., endocarditis)VasculitisHypercoagulable statesNonocclusiveSplanchnic VasoconstrictionHypovolemiaHypotensionLow cardiac outputVasopressor agents useD.Risk Factors for AMI. The most common predisposing conditions are depicted in Table [6.4](#Tab6_4_69880_2_En){ref-type="table"}. Table 6.4.Risk Factors for the Development of AMI--- Age ≥50 years--- Atherosclerotic heart disease--- Congestive heart failure--- Recent myocardial infarction--- Valvular heart diseaseE.Diagnostic EvaluationHistory and Physical ExaminationThe classic complaint of severe abdominal pain that is out of proportion to the findings of physical examination, in our experience, is rarely seen. If peritoneal signs are present (e.g., rebound tenderness), intestinal infarction is likely to have occurred. Abdominal distention, emesis, and other signs of intestinal obstruction may occur in patients with AMI in situ. Lower GI bleeding may occur.Laboratory Studies RevealLeukocytosis in 75% of patientsMetabolic acidosisElevated amylase, creatine kinase (CK) (6--12 h after infarction has occurred), lactate, and phosphateRadiologic Evaluation should be done as soon as the patient has been adequately resuscitated (including measures aimed at relieving acute congestive heart failure and hypotension, correction of hypovolemia and cardiac dysrhythmias)Plain Abdominal X-RaysUseful in excluding other causes of abdominal pain (i.e., mechanical obstruction, perforation)Seventy percent of patients will show at least one of the following:IleusAscitesSmall bowel dilationSeparation of small bowel loopsThickening of *valvulae conniventes*Thumb printingBarium studies are *contraindicated* in these patients and they interfere with arteriography.Computed tomography (CT) may be particularly valuable when mesenteric vein thrombosis is being considered. It may show focal or segmental bowel wall thickening or intestinal pneumatosisArteriography: For adequate study, the patient needs to be hemodynamically stable. Early use of this test is the key to diagnosis. It provides a "road map" for the surgeon.LaparotomyTherapyAs in any critically ill patient, the management of AMI starts with assessment of the ABCs.Adequate hydration. If necessary, provide invasive hemodynamic monitoring to maximize cardiac output, oxygen delivery, and volume status.Patients with suspected embolic or thrombotic occlusion should undergo *urgent* laparotomy for possible resection. Heparin and broad-spectrum antibiotic are indicated before surgery. Most patients will undergo a "second-look" operation within 24 h of the initial laparotomy.In those cases with nonocclusive AMI, intra-arterial infusions of vasodilators (e.g., papaverine 30--60 mg/h) are advocated by some.

Fulminant Hepatic Failure and Encephalopathy {#Sec3}
============================================

A.DefinitionAcute Fulminant Hepatic FailureAcute fulminant hepatic failure (FHF) is defined as acute liver failure associated with the development of hepatic encephalopathy within 8 weeks of the onset of symptoms attributable to hepatocellular dysfunction. This definition assumes that there is no preexisting liver disease.Hepatic EncephalopathyHepatic encephalopathy (HE) is a complex neuropsychiatric syndrome precipitated by abnormal liver function. This syndrome is a feature of acute and/or chronic hepatocellular failure.B.EtiologyCommon causes of FHF and HE are depicted in Table [6.5](#Tab6_5_69880_2_En){ref-type="table"}. Table 6.5.Causes of Acute Liver Failure1. Viral hepatitis (i.e., A, B, C)2. Drugs or toxinsAcetaminophenAcute alcohol intoxicationCarbon tetrachlorideHalothaneIsoniazidMonoamine oxidase inhibitorsMushroom poisoning3. Fatty liver of pregnancy4. Shock of any etiology5. Massive liver infiltration (i.e., leukemia)6. Decompensation of chronic liver failureC.Diagnostic Evaluation HistoryA detailed history should be obtained from family members. The following points need to be investigated:History of preexisting liver diseaseDrug or alcohol useToxin exposure or ingestionPhysical ExaminationThis may vary from the patient in no distress to the patient in overt shock.Vital signs: tachycardia, hypotension.Associated findings: petechiae, jaundice, hepatomegaly, splenomegaly.The encephalopathy may begin with confusion, disorientation, and irrational behavior. Coma may develop rapidly. (See Table [6.6](#Tab6_6_69880_2_En){ref-type="table"}.) Table 6.6.Clinical Stages of Hepatic EncephalopathyStageNeurological findingsIConfusion, mild changes in personality, psychometric defectsIIDrowsiness to lethargyIIISomnolent but arousableIVComaLaboratory and Radiologic EvaluationAll patients with HE and/or FHF should undergo the following tests:Chest x-ray, abdominal x-rays.Blood glucose may reveal hypoglycemia.Serum bilirubin: A value \>23 mg/dL is the best predictor of nonsurvival.AST and ALT have little prognostic value as levels tend to fall as the patient's condition worsens.Serum albumin: Its decrease reflects poor outcome.Serum electrolytes.Complete blood count.Head computed tomography (CT) scan to rule out a structural lesion (e.g., hemorrhage).Lumbar puncture needs to be considered and performed if meningitis is suspected.If the etiology of FHF is unknown, the following need to be ordered:Acetaminophen levelHepatitis profileViral hepatitis A is diagnosed by detection of HAV-IgM in the patient's serum.Viral hepatitis B is diagnosed by i. Detection of HBsAgii. Anti-HB~c~ IgMViral hepatitis C is diagnosed by detection of anti-HCV.Delta virus hepatitis is diagnosed by detection of anti-HDV in a patient co-infected with hepatitis B virus.Alkaline phosphataseAmylaseSerum ammonia levelElectroencephalograms (EEGs) are used to assess clinical response and prognosis in patients with HE.D.Complications of FHFWhen the liver fails acutely, all organ systems are involved to some extent.Central Nervous System (CNS)Hepatic encephalopathy, cerebral edemaCardiovascularDysrhythmias (particularly in patients with advanced FHF), hypotensionPulmonaryHypoxemia advancing to adult (acute) respiratory distress syndrome (ARDS)RenalThe development of renal failure with FHF carries a poor prognosis.In most instances the renal failure is related to "prerenal" causes.The *hepatorenal syndrome* is a diagnosis of exclusion. It is associated with a normal urine sediment, a urinary sodium concentration of \<20 mmol/L, and resolution if liver function improves.HematologicThrombocytopenia, diminished clotting factors with episodes of severe bleeding.InfectionSusceptibility to infection is increased in patients with FHF.MetabolicHypoglycemia, metabolic acidosis, hypokalemia, hyponatremia.E.ManagementSupportive TherapyAs in any critically ill patient, the management of AMI starts with assessment of the ABCs.The usual indications for endotracheal intubation and assisted mechanical ventilation apply to these patients.The use of corticosteroids for patients with FHF has not been proven to improve survival and, indeed, may worsen the clinical picture.Some authors suggest avoiding parenteral nutrition, as protein and amino acids may worsen the clinical picture. However, new total parenteral nutrition solutions with "branched-chain" amino acids are probably efficacious and help maintain a positive-nitrogen balance.The management of FHF-associated cerebral edema is no different from that for non-hepatic-related causes (see 10.1007/978-0-387-92851-9, "Neurologic Disorders"). In recent years, emphasis on the use of therapeutic hypothermia for these patients seems encouraging.Some clinical and experimental evidence shows that the benzodiazepine antagonist flumazenil (Romazicon) may have some role in improving the signs and symptoms of HE.Investigational data have shown some improvement in the hemodynamics of patients with FHF treated with n-acetylcysteine.Liver transplantation may be an alternative form of therapy (in a few specialized transplant centers) for some patients with no known contraindication to the procedure.Liver "dialysis": A few specialized centers are currently exploring this form of therapy.Agents aimed at stimulating ammonia metabolism have also been tried (e.g., ornithine-aspartate, sodium benzoate)

Pancreatitis {#Sec4}
============

A.Definition. Acute pancreatitis is an inflammatory process of the pancreas with a wide range of clinical severity ranging from self-limited to a lethal disease, complicated by multiple organ system failure (10% of cases).B.Etiology. The most common causes of pancreatitis areAlcoholismGallstonesHyperlipidemiaTrauma (blunt or penetrating)Infections (i.e., mumps, mycoplasma)Hypoperfusion states (i.e., shock, cardiopulmonary bypass)HypercalcemiaDrugs (i.e., sulfonamides, thiazides)C.Diagnostic EvaluationHistoryNinety-five percent of patients with acute pancreatitis present with abdominal pain, of which 50% will present with upper abdominal discomfort radiating to the back. Nausea and vomiting are also present.Physical ExaminationDepending on the severity of the situation, the patient may have overt signs of shock or may be hemodynamically stable. Other findings include the following:Abdominal tenderness and distentionAbdominal ileusLow-grade fever (Note: a fever \>39°C should suggest cholangitis, peritonitis, or a pancreatic abscess.)Mild jaundiceAscitesPleural effusionLaboratory EvaluationComplete Blood Count (CBC): Shows marked leukocytosis. Thrombocytopenia may be present in those cases complicated by disseminated intravascular coagulation (DIC).Amylase: Elevated initially, but may decrease after 2--3 days if necrosis of the pancreas is widespread. False-positive results may occur in perforation of the esophagus, stomach, intestine, gynecologic disorders, renal failure, severe burns, diabetic ketoacidosis (DKA), salivary gland disorders, and macroamylasemia.Lipase: Hyperlipasemia persists longer than hyperamylasemia. However, if necrosis of the pancreas is widespread, these values may be normal.Serum calcium is usually low. When levels are \<8 mg/dL, the prognosis is poor.Other electrolyte imbalances as well as hyperglycemia are usually present.Metabolic acidosis may be present.C-reactive protein: Usually elevated.Urinalysis may reveal proteinuria, casts (25% of the cases), and glycosuria.Radiologic EvaluationEvery patient with suspected acute pancreatitis should get a chest x-ray (to rule out free air under the diaphragm, evidence of pleural effusions, etc.) and an abdominal x-ray (signs of intestinal obstruction, ileus, gallstones, the so-called "sentinel loop" of pancreatitis, or the colon "cut-off" sign, etc.). In addition, when the diagnosis remains in doubt, especially in the more severely ill, the following can be obtained:Ultrasonography (US) is the modality of choice in patients with edematous pancreatitis or suspected biliary pancreatitis and to follow up phlegmon or abscesses. Unfortunately, US cannot be accurately performed in obese patients and in those with moderate-to-severe ileus.CT is the most useful tool in assessing the retroperitoneum. Its use in acute pancreatitis is mainly to follow up on significant complications (i.e., abscess, phlegmon, pseudoaneurysms).D.ManagementAs in any critically ill patient, the management of acute pancreatitis starts with assessment of the ABCs.Adequate hydration.Correct underlying factors.Control pancreatic enzyme secretion.Nasogastric suctionProton-pump inhibitors (e.g., pantoprazole 40 mg IV q12 h) or H~2~-receptor-blocking agents (e.g., ranitidine \[Zantac\] 300-mg/24 h IV infusion if renal function is normal or famotidine 20 mg IV q12 h).Many clinicians use the following agents in acute pancreatitis; however, clinical studies have not supported the routine use of these agents:Calcitonin (300 IU/24 h)Somatostatin (250 μg IV bolus, then 250 μg/h as IV drip).GlucagonOf interest is the use of intramuscular (IM) clonidine (not yet available in the United States) for patients hemodynamically stable with acute pancreatitis. Preliminary data show encouraging results.Sedation and analgesia: Patients may require substantial amounts of analgesia, usually with meperidine (Demerol).Adequate parenteral nutrition (see 10.1007/978-0-387-92851-10, "Nutrition").Correct hypocalcemia *only* if there is clinical evidence of tetany.E.Complications. The most common complications of acute pancreatitis are depicted in Table [6.7](#Tab6_7_69880_2_En){ref-type="table"}.Those patients who demonstrate fever \>39°C with a white blood cell count \>20,000/mm^3^ should be evaluated for the presence of a pancreatic abscess (with the use of CT). If there are any fluid collections, CT-guided fine-needle aspiration is then indicated (for Gram's stain and cultures).If the suspected diagnosis is pancreatic abscess, broad-spectrum antibiotics should be started and an emergent surgical consultation obtained.Some authors advocate necrosectomy in patients with necrotizing pancreatitis.F.PrognosisIn assessing the severity of the disease and prognosis, several classifications have been used. The most commonly utilized is the *Ranson's criteria* (initially developed for patients with alcoholic pancreatitis):Three or more of the following criteria must be met:Age \>55 yearsWhite blood cell count \>16,000/mm^3^Glucose \>200 mg/dLBase deficit \>4 mEq/LLactic dehydrogenase (LDH) \>350 IU/LAST (serum glutamate pyruvate transaminase \[SGPT\]) \>250 IU/L)Development of the following within 48 h indicates a worsening prognosis:Hematocrit drop \>10%Serum urea nitrogen (BUN) rise \>5 mg/dLPartial pressure of O~2~ in arterial blood (PaO~2~) \<60 torr (mmHg)Calcium \<8 mg/dLFluid sequestration \>6 LMortality rates correlate with the number of criteria present:0--2 criteria, 1% mortality3--4 criteria, 16% mortality5--6 criteria, 40% mortality7--8 criteria, 100% mortalityIntensive care management and prompt surgical consultation have lowered the mortality of acute pancreatitis. Table 6.7.Complications of Acute Pancreatitis1. Intravascular fluid depletiona. Prerenal azotemiab. Shock2. ARDS (3--7 days after the onset)3. Cardiac dysfunction4. Pancreatic abscess5. Pancreatic pseudocysts6. Chronic pancreatitis7. Permanent diabetes mellitus8. Multiorgan system failure

Useful Facts And Formulas {#Sec5}
=========================

A.**Intestinal Transit**. The normal 24-h *intestinal fluid and electrolyte transport* is depicted in Table [6.8](#Tab6_8_69880_2_En){ref-type="table"}.B.**Stool Formulas**. As part of the diagnostic workup of patients with diarrhea, *stool osmolal gap* (SOG) is usually calculated utilizing the following formula:$$\documentclass[12pt]{minimal}
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$${\rm{SOG = stool\; osmolality }} - {\rm{ 2 }} \times {\rm{ (stool Na}}^{\rm{ + }} {\rm{ + stool K}}^{\rm{ + }} {\rm{)}}
$$
\end{document}$$Normal stool osmolality is \<290 mOsm/L. If the SOG \>100, it indicates an osmotic diarrhea.C.**Liver Facts**. The *Child's classification* for portal hypertension is commonly used in critically ill patients and is depicted in Table [6.9](#Tab6_9_69880_2_En){ref-type="table"}. Table 6.8.Normal 24-h Intestinal Fluid and Electrolyte TransportSiteFluid received (L)Amount absorbed (L)Electrolyte absorptionNa^+^K^+^Cl^--^Duodenum/ jejunum9.04.0PassivePassivePassiveIleum5.03.5ActivePassivePassiveColon1.51.35ActivePassiveActive Table 6.9.Child's Classification of Portal HypertensionClassABCSerum bilirubin (mg/dL)\<22--3\>3Serum albumin (g/dL)\>3.53--3.5\<3AscitesNoneEasily controlledPoorly controlledEncephalopathyNoneMinimalAdvancedNutritionExcellentGoodPoor
